You are currently viewing a new version of our website. To view the old version click .

Photobiomodulation for Parkinson's Disease

Special Issue Information

Dear Colleagues,

Parkinson's disease is a neurological disorder with cardinal signs of resting tremor, akinesia, bradykinesia, lead-pipe rigidity, and postural instability. Two key features of the disease are that there is a rather targeted degeneration of a particular neurotransmitter system (i.e., dopaminergic) and that this degeneration is progressive, with more and more neurones dying over time. The current treatments are effective in treating motor signs, but not, however, in slowing the relentless progression of the degeneration. Recently, photobiomodulation—the use of red to near-infrared light on body tissues—has been reported to slow this neurodegeneration in a range of animal models, from flies to monkeys. There are also some encouraging, early reports that photobiomodulation results in many beneficial outcomes in patients. This Special Issue will explore various aspects of this new and exciting treatment in animal models and in patients, building on the template of findings needed to develop this treatment into a viable therapeutic option for patients. 

Prof. John Mitrofanis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Parkinson's disease
  • neurodegeneration
  • neuroprotection
  • microbiome
  • dopamine
  • red to near-infrared light
  • animal models
  • patients
  • fMRI

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomolecules - ISSN 2218-273X